NCT04002479View on ClinicalTrials.gov

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

NARecruitingINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Pancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Interventions
DEVICE

Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

An intratumoral insertion of radioactive sources \[Ra-224 containing stainless-steel 316LVM tubes- (Alpha DaRT seeds)\]. The seeds release by recoil into the tumor short-lived alpha-emitting atoms.

Trial Locations (2)

Unknown

RECRUITING

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

RECRUITING

Jewish General Hospital, Montreal

Sponsors
All Listed Sponsors
lead

Alpha Tau Medical LTD.

INDUSTRY